Physician profile
Hannah Caroline Power
NPI 1548918154
$624.53
in general payments reported to CMS, 2019-2025
15 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $100 · 2024: $336 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600 · Entertainment: $24.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.38 |
| Entertainment | $24.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $93.24 | 2023-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $76.37 | 2023-2024 | |
| Novo Nordisk INC | $70.75 | 2023-2024 | Rybelsus, Ozempic |
| Tris Pharma INC | $64.31 | 2025 | Dyanavel Xr |
| Abbvie INC. | $63.44 | 2023-2024 | |
| Vertical Pharmaceuticals, LLC | $40.51 | 2025 | Relexxii |
| Astrazeneca Pharmaceuticals LP | $39.16 | 2024 | Farxiga |
| Supernus Pharmaceuticals, INC. | $37.60 | 2025 | Qelbree |
| Corium, LLC | $29.51 | 2025 | Azstarys |
| Optos, INC. | $24.15 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.57 | 2024 | Jardiance |
| Inspire Medical Systems, INC. | $19.09 | 2024 | Inspire |
| Lilly USA, LLC | $17.09 | 2024 | Mounjaro |
| Abbott Laboratories | $16.52 | 2025 | Freestyle Libre 3 |
| Currax Pharmaceuticals LLC | $13.22 | 2024 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Power listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.